Nexien BioPharma Inc (NXEN)

[Farmer7]

There are a lot of big players on the board of NTVA. Millionaires and even a billionaire! Add their scientific studies taking place, all of which will be going for orphan drug status and we have a winner here.

GWP$ has about a 3 billion dollar market cap with just two drugs in orphan drug status. So if you figure their market cap is based on a billion dollars per product and the other billion is due to hype and being the first company to do what they're doing, we can break down and identify where we might be one day.

We currently have six studies we're going for orphan drug status. Let's say 2 out of the six get accepted. In theory, that would give us a 2 billion dollar market cap. Let's assume we have dilution going on, and the share count raises to 50 million for easy figuring. This would create a share price of $40 per share.

Will this happen in 2018 or 2019? Highly doubtful. But, it could happen in 2020 and beyond as some of these studies reach into the human efficacy stage.

This is just my opinion, but one worth thinking about.